BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34412797)

  • 1. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
    Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
    JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
    Mangner N; Farah A; Ohlow MA; Möbius-Winkler S; Weilenmann D; Wöhrle J; Linke A; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Scheller B; Jeger RV;
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e011325. PubMed ID: 35000455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
    Seeger J; Wöhrle J; Scheller B; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger R; On Behalf Of The Basket-Small Investigators
    J Cardiovasc Dev Dis; 2023 Mar; 10(3):. PubMed ID: 36975883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
    Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease.
    Megaly M; Buda K; Saad M; Tawadros M; Elbadawi A; Basir M; Abbott JD; Rinfret S; Alaswad K; Brilakis ES
    Cardiovasc Revasc Med; 2022 Feb; 35():76-82. PubMed ID: 33858783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
    Mahfoud F; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Kaiser C; Cattaneo M; Scheller B; Jeger RV
    Clin Res Cardiol; 2022 Jul; 111(7):806-815. PubMed ID: 35220449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
    Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.
    Cortese B; Testa G; Rivero F; Erriquez A; Alfonso F
    JACC Cardiovasc Interv; 2023 May; 16(9):1054-1061. PubMed ID: 37164603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.
    Gilgen N; Farah A; Scheller B; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Jamshidi P; Leibundgut G; Möbius-Winkler S; Zweiker R; Krackhardt F; Butter C; Bruch L; Kaiser C; Hoffmann A; Rickenbacher P; Mueller C; Stephan FP; Coslovsky M; Jeger R;
    Clin Cardiol; 2018 May; 41(5):569-575. PubMed ID: 29527709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease.
    Her AY; Shin ES; Kim S; Kim B; Kim TH; Sohn CB; Choi BJ; Park Y; Cho JR; Jeong YH
    Cardiovasc Diabetol; 2023 May; 22(1):120. PubMed ID: 37210516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
    Rubini Gimenez M; Scheller B; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Cattaneo M; Gilgen N; Kaiser C; Jeger RV
    Clin Res Cardiol; 2023 Jul; ():. PubMed ID: 37495797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial.
    Kurz DJ; Bernheim AM; Tüller D; Zbinden R; Jeger R; Kaiser C; Galatius S; Hansen KW; Alber H; Pfisterer M; Eberli FR
    Am Heart J; 2015 Oct; 170(4):787-795.e1. PubMed ID: 26386803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
    Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
    Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
    Scheller B; Rissanen TT; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Coslovsky M; Mahfoud F; Jeger RV;
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e011569. PubMed ID: 35411792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
    Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
    JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
    Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
    JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.